Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0002013869-25-000002
Filing Date
2025-11-17
Accepted
2025-11-17 16:05:46
Documents
1
Period of Report
2025-11-14

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 8786
  Complete submission text file 0002013869-25-000002.txt   10330
Mailing Address 1500 LIBERTY RIDGE DRIVE SUITE 321 WAYNE PA 19087
Business Address 1500 LIBERTY RIDGE DRIVE SUITE 321 WAYNE PA 19087 410-522-8707
Avalo Therapeutics, Inc. (Issuer) CIK: 0001534120 (see all company filings)

EIN.: 450705648 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850
Business Address
Goldman Jonathan (Reporting) CIK: 0002013869 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37590 | Film No.: 251491100